The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the Medi Division of the American Chemical Society (ACS) and the European Federation for Medicinal Chemistry (EFMC).
Frontiers 2015 will take place in Antwerp, Belgium, from September 14-16, 2015. It will be jointly organised by EFMC, ACS and the local Dutch and Belgian organisers: the Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV, Belgium), the Société Royale de Chimie (SRC, Belgium), and the Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV, The Netherlands).
This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. It attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for Frontiers 2015 will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.
Sessions
The following Sessions will be part of the Scientific Programme:
- Plenary Lectures
Session Chair: Koen Augustyns (University of Antwerp, Belgium) - Molecular Chaperones and their Therapeutic Potential
Session Chair: Brian Blagg (University of Kansas, United States) - Unexplored Chemical Space: Experiences from the European Lead Factory and the NIH Molecular Libraries Programme
Session Chair: Peter Molenveld (Mercachem, The Netherlands) - Emerging Advances in GPCR Research
Session Chair: Laurent Provins (UCB Biopharma, Belgium) - Emerging Topics
Session Chair: Hans Ulrich Stilz (Novo Nordisk, Denmark) - Non-Small Molecules
Session Chair: Steve Firestine (Wayne State University, United States) - Novel Strategies for Anti-Thrombotic Therapy
Session Chairs: Amy Ripka (WuXi Apptec, Unites States) & Amjad Ali (Merck, United States) - Kinetics and Thermodynamics of Ligand Binding
Session Chair: Laura Heitman (University of Leiden, The Netherlands) - Rational Design of Non-Oral Drugs
Session Chair: Jordi Gràcia (Almirall, Spain) - Academic Drug Discovery
Session Chair: Henk Timmerman (VU University Amsterdam, The Netherlands) - Non-Small Molecules
Session Chair: Steve Firestine (Wayne State University, United States)
Call for Abstracts
All participants are invited to register and submit abstracts of scientific communications for poster presentations. The submitted abstracts will be reviewed for their acceptance by the Organising Committee. The accepted abstracts will be published in the book of abstracts distributed to all symposium attendants.
- Deadline for early bird fees is June 2, 2015
- Deadline for abstract submission for poster presentations is July 15, 2015
Find out more on www.frontiers2015.org